EU: European scientists show how drug side effects could provide new medicines
September 1st, 2008 By Alan Osborn
A study by European researchers has suggested that new uses might be found for marketed drugs based on unwanted side effects. A striking example is the drug Viagra which was initially developed to treat angina but where its side effects of prolonged penile erection led to the development of a new blockbuster drug.
The new study, by researchers at the European Molecular Biology Laboratory (EMBL), envisages a computational method that compares the similarity of the side effects of different drugs and predicts how likely it is that ...
A study by European researchers has suggested that new uses might be found for marketed drugs based on unwanted side effects. A striking example is the drug Viagra which was initially developed to treat angina but where its side effects of prolonged penile erection led to the development of a new blockbuster drug.
The new study, by researchers at the European Molecular Biology Laboratory (EMBL), envisages a computational method that compares the similarity of the side effects of different drugs and predicts how likely it is that ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.